Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases
A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhi...
Gespeichert in:
Veröffentlicht in: | Biochemical pharmacology 1987-06, Vol.36 (12), p.1869-1879 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1879 |
---|---|
container_issue | 12 |
container_start_page | 1869 |
container_title | Biochemical pharmacology |
container_volume | 36 |
creator | Ashour, Mohamed-Bassem A. Hammock, Bruce D. |
description | A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and
p-nitrophenyl acetate (
p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e.
K
m, V
max and
(
T
1
2
)
e
] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice. |
doi_str_mv | 10.1016/0006-2952(87)90483-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77560388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006295287904837</els_id><sourcerecordid>14798980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</originalsourceid><addsrcrecordid>eNqFkUuLFDEURoMoY9v6DxRqIaJgaVJJ57EZkMEXDLhQVy7CTXKD0apKm6QG599bbTe91FVIvnMfnBDymNFXjDL5mlIq-8HshudavTBUaN6rO2TDtOLrs9R3yeaM3CcPav1xuGrJLsgF3xnOjdmQb58XV1tqS8PQtZLiuOSSf2LLM9YOarfPDef2sqs4om_pBrs0f08utVxql2M3wTTBmGDuPBSXf9-OWBsWqFgfknsRxoqPTueWfH339svVh_760_uPV2-uey8kbz0TBoBKz51RkXonjDJBRKFcgEil4NrDID1yH2CAiM4BhiGo6ECFgUa-Jc-Offcl_1rW8XZK1eM4wox5qVapnaRc6_-CTCijjaYrKI6gL7nWgtHuS5qg3FpG7UG-Pai0B7NWK_tXvlVr2ZNT_8VNGM5FJ9tr_vSUQ_UwxgKzT_WMKcmMWMktuTxiuEq7SVhs9QlnjyGV9Q9syOnfe_wBAlej3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14798980</pqid></control><display><type>article</type><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</creator><creatorcontrib>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</creatorcontrib><description>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and
p-nitrophenyl acetate (
p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e.
K
m, V
max and
(
T
1
2
)
e
] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(87)90483-7</identifier><identifier>PMID: 3593399</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; carboxylesterase ; Carboxylic Ester Hydrolases - antagonists & inhibitors ; Chemical and industrial products toxicology. Toxic occupational diseases ; Ketones - pharmacology ; Kinetics ; liver ; Malathion - pharmacology ; Medical sciences ; Mice ; Microsomes, Liver - enzymology ; Nitrophenols - pharmacology ; Species Specificity ; Structure-Activity Relationship ; Succinates - pharmacology ; Swine ; Toxicology ; trifluoroketone ; Various organic compounds</subject><ispartof>Biochemical pharmacology, 1987-06, Vol.36 (12), p.1869-1879</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</citedby><cites>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0006295287904837$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7619493$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3593399$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ashour, Mohamed-Bassem A.</creatorcontrib><creatorcontrib>Hammock, Bruce D.</creatorcontrib><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and
p-nitrophenyl acetate (
p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e.
K
m, V
max and
(
T
1
2
)
e
] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>carboxylesterase</subject><subject>Carboxylic Ester Hydrolases - antagonists & inhibitors</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Ketones - pharmacology</subject><subject>Kinetics</subject><subject>liver</subject><subject>Malathion - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microsomes, Liver - enzymology</subject><subject>Nitrophenols - pharmacology</subject><subject>Species Specificity</subject><subject>Structure-Activity Relationship</subject><subject>Succinates - pharmacology</subject><subject>Swine</subject><subject>Toxicology</subject><subject>trifluoroketone</subject><subject>Various organic compounds</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUuLFDEURoMoY9v6DxRqIaJgaVJJ57EZkMEXDLhQVy7CTXKD0apKm6QG599bbTe91FVIvnMfnBDymNFXjDL5mlIq-8HshudavTBUaN6rO2TDtOLrs9R3yeaM3CcPav1xuGrJLsgF3xnOjdmQb58XV1tqS8PQtZLiuOSSf2LLM9YOarfPDef2sqs4om_pBrs0f08utVxql2M3wTTBmGDuPBSXf9-OWBsWqFgfknsRxoqPTueWfH339svVh_760_uPV2-uey8kbz0TBoBKz51RkXonjDJBRKFcgEil4NrDID1yH2CAiM4BhiGo6ECFgUa-Jc-Offcl_1rW8XZK1eM4wox5qVapnaRc6_-CTCijjaYrKI6gL7nWgtHuS5qg3FpG7UG-Pai0B7NWK_tXvlVr2ZNT_8VNGM5FJ9tr_vSUQ_UwxgKzT_WMKcmMWMktuTxiuEq7SVhs9QlnjyGV9Q9syOnfe_wBAlej3g</recordid><startdate>19870615</startdate><enddate>19870615</enddate><creator>Ashour, Mohamed-Bassem A.</creator><creator>Hammock, Bruce D.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19870615</creationdate><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><author>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>carboxylesterase</topic><topic>Carboxylic Ester Hydrolases - antagonists & inhibitors</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Ketones - pharmacology</topic><topic>Kinetics</topic><topic>liver</topic><topic>Malathion - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microsomes, Liver - enzymology</topic><topic>Nitrophenols - pharmacology</topic><topic>Species Specificity</topic><topic>Structure-Activity Relationship</topic><topic>Succinates - pharmacology</topic><topic>Swine</topic><topic>Toxicology</topic><topic>trifluoroketone</topic><topic>Various organic compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashour, Mohamed-Bassem A.</creatorcontrib><creatorcontrib>Hammock, Bruce D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashour, Mohamed-Bassem A.</au><au>Hammock, Bruce D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1987-06-15</date><risdate>1987</risdate><volume>36</volume><issue>12</issue><spage>1869</spage><epage>1879</epage><pages>1869-1879</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and
p-nitrophenyl acetate (
p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e.
K
m, V
max and
(
T
1
2
)
e
] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>3593399</pmid><doi>10.1016/0006-2952(87)90483-7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-2952 |
ispartof | Biochemical pharmacology, 1987-06, Vol.36 (12), p.1869-1879 |
issn | 0006-2952 1873-2968 |
language | eng |
recordid | cdi_proquest_miscellaneous_77560388 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Biological and medical sciences carboxylesterase Carboxylic Ester Hydrolases - antagonists & inhibitors Chemical and industrial products toxicology. Toxic occupational diseases Ketones - pharmacology Kinetics liver Malathion - pharmacology Medical sciences Mice Microsomes, Liver - enzymology Nitrophenols - pharmacology Species Specificity Structure-Activity Relationship Succinates - pharmacology Swine Toxicology trifluoroketone Various organic compounds |
title | Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substituted%20trifluoroketones%20as%20potent,%20selective%20inhibitors%20of%20mammalian%20carboxylesterases&rft.jtitle=Biochemical%20pharmacology&rft.au=Ashour,%20Mohamed-Bassem%20A.&rft.date=1987-06-15&rft.volume=36&rft.issue=12&rft.spage=1869&rft.epage=1879&rft.pages=1869-1879&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(87)90483-7&rft_dat=%3Cproquest_cross%3E14798980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14798980&rft_id=info:pmid/3593399&rft_els_id=0006295287904837&rfr_iscdi=true |